Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Osteoporosis Treatment Market (2017-2025): Analysis By Drug Type & Geography - Research and Markets

Research and Markets
Posted on: 21 Dec 17

The "Global Osteoporosis Treatment Market, 2017 to 2025" report has been added to Research and Markets' offering.

The global osteoporosis treatment market was valued at US$ 11,734.8 Mn in 2016, and is expected to reach US$ 16,512.7 Mn by 2025, expanding at a CAGR of 3.9% from 2017 to 2025

Osteoporosis is a bone disease causing loss of bone density that occurs with age. It leads to million broken bones each year, and thus major reason of fractures, spinal problems, back pain, and loss of independence. According to the International Osteoporosis Foundation, around 200 million people suffer from this disease. Around 30% of all postmenopausal women suffer from osteoporosis in U.S. and Europe. It is observed that osteoporosis is one of the most neglected diseases despite the grave consequence it can cause to female health. Thus rising prevalence of osteoporosis is a serious public health concern. Programs to increase awareness of osteoporosis are conducted out by international and national bodies. Thus ageing population, rise in prevalence of osteoporosis, awareness programs are the key factors driving the osteoporosis treatment market.

The global osteoporosis treatment market is segmented by drug type into bisphosphonates, parathyroid hormone therapy, calcitonin, selective estrogen inhibitors modulator (SERM) and rank ligand inhibitors. Bisphosphonates is extensively used for prevention and treatment of osteoporosis, thus dominating the osteoporosis treatment market.

Companies Mentioned

  • Allergan Plc
  • Amgen, Inc.
  • Actavis Plc.
  • Eli Lilly and Company
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Pharmaceutical Ltd.
  • Merck & Co AG
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Others

Key Topics Covered:

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Osteoporosis Treatment: Market Dynamics and Future Outlook

Chapter 4. Global Osteoporosis Treatment Market, by Drug Type, 2015 - 2025 (US$ Mn)

Chapter 5. Global Osteoporosis Treatment Market, by Geography, 2015 - 2025 (US$ Mn)

Chapter 6. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/5rhnm8/global

View source version on businesswire.com: http://www.businesswire.com/news/home/20171221005284/en/

Business Wire
www.businesswire.com

Last updated on: 21/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.